Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cafcit for primary apnea of prematurity
CTR20140706Phase 4Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of caffeine in apnea of prematurity (AOP), sponsored by Chiesi Farmaceutici S.p.A.. Started Oct 2014; status: completed.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on CTR20140706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140706.